or Try an Advanced Search...

    Technical Analysis for BCT - Briacell Therapeutics Corp.

    Grade Last Price % Change Price Change
    F 1.130 -9.60% -0.120
    BCT closed down 9.6 percent on Wednesday, October 16, 2024, on 69 percent of normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Down
    Historical BCT trend table...
    Date Alert Name Type % Chg
    Fell Below 20 DMA Bearish 0.00%
    MACD Bearish Signal Line Cross Bearish 0.00%
    1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
    Wide Bands Range Expansion 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Spinning Top Other -9.60%
    Narrow Range Bar Range Contraction -9.60%
    Wide Bands Range Expansion -9.60%
    Gapped Down Weakness -9.60%
    Older End-of-Day Signals for BCT ...

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    BCT Chart by TradingView
    Basic chart:

    Profile

    Briacell Therapeutics Corp. Description

    BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company. The Company is engaged in the research and development of cancer immunotherapy technology. The Company offers BriaVax, an immunotherapy vaccine. The Company is engaged in developing and advancing its BriaVax immunotherapy vaccine for patients with advanced breast cancer. The Company is also engaged in the research and development of its companion diagnostic product, BriaDx. The Company's BriaDx program is focused on analyzing samples obtained from patients previously treated with BriaVax along with co-analysis of previously manufactured vaccine lots. The Company's analysis methods include various technologies, including gene expression profiling by Illumina microarrays and human leukocyte antigen (HLA) typing by a high-resolution method. The Company is focused on understanding the mechanism of action (MoA) of BriaVax.

    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Cancer Medical Specialties Therapy Oncology Immunology Antigen Immunotherapy Cancer Immunotherapy Biotechnology Companies Breast Cancer Vaccine

    Is BCT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 8.0
    52 Week Low 0.64
    Average Volume 59,255
    200-Day Moving Average 2.878
    50-Day Moving Average 1.007
    20-Day Moving Average 1.162
    10-Day Moving Average 1.327
    Average True Range 0.211
    RSI (14) 48.98
    ADX 43.59
    +DI 30.755
    -DI 19.072
    Chandelier Exit (Long, 3 ATRs) 1.279
    Chandelier Exit (Short, 3 ATRs) 1.272
    Upper Bollinger Bands 1.650
    Lower Bollinger Band 0.673
    Percent B (%b) 0.47
    BandWidth 84.046
    MACD Line 0.088
    MACD Signal Line 0.094
    MACD Histogram -0.0055
    Fundamentals Value
    Market Cap 872.32 Thousand
    Num Shares 772 Thousand
    EPS -0.04
    Price-to-Earnings (P/E) Ratio -29.74
    Price-to-Sales 0.00
    Price-to-Book 10.01
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.340
    Resistance 3 (R3) 1.360 1.310 1.305
    Resistance 2 (R2) 1.310 1.257 1.300 1.293
    Resistance 1 (R1) 1.220 1.223 1.195 1.200 1.282
    Pivot Point 1.170 1.170 1.158 1.160 1.170
    Support 1 (S1) 1.080 1.117 1.055 1.060 0.978
    Support 2 (S2) 1.030 1.083 1.020 0.967
    Support 3 (S3) 0.940 1.030 0.955
    Support 4 (S4) 0.920